Blueprint Medicines Corporation (BPMC) P/E US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 19.5 | -9.73 | 0.00 | 0.00 | -81.7 | -36.1 | ||
| Changes by years, y/y, % | -267% | -150% | -100% | +47.6% | |||||
Blueprint Medicines Corporation. P/E
Blueprint Medicines Corporation. P/E, changes, %
Blueprint Medicines Corporation (BPMC) P/E US GAAP (quarter values) |
||||||||
| FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| P/E | ? | 0.00 | 0.00 | -45.8 | -82.7 | -36.1 | -36.1 | |
| Changes by years, y/y, % | -100% | -100% | ||||||
| Changes by quarters, q/q, % | +81% | -56% | ||||||